Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

Part of paid clinical trials in Orlando, Florida.

Sponsor
Viome
Study ID
NCT04957511
Status
Recruiting
Apply to this trial

Conditions

  • Gut Microbiome
  • Gynecologic Cancer
  • Immunotherapy

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

30 participants with advanced or recurrent gynecological cancer from are enrolled for this study. Eligible participants then provide fecal specimen, blood, vaginal swab, oral mucosal swab and receive food dietary recommendation. Additional samples are collected for results analysis.

Key Dates

Start date
Jun 29, 2021
Status verified
Jan 2025
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
30 participants (estimated)

Primary Outcome Measure

Microbiome change through analysis of biological samples (fecal specimen, blood, vaginal swab, oral mucosal swab). [ Time Frame: ~2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
AdventHealth Cancer InstituteOrlandoFlorida32804
Jessica Chestnut
[email protected]
407 303 2451
Nathalie McKenzie, MD (PRINCIPAL_INVESTIGATOR)
Robert Holloway, MD (SUB_INVESTIGATOR)
James Kendrick, MD (SUB_INVESTIGATOR)

Find similar trials in Orlando, FL

By research site
AdventHealth Cancer Institute· Orlando, FL

Related Studies